Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms
- PMID: 29991558
- PMCID: PMC6194341
- DOI: 10.1182/blood-2018-06-858597
Familial risks of acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms
Conflict of interest statement
Conflict-of-interest disclosure: The authors declare no competing financial interests.
Figures
Comment on
- Arber doi: 10.1182/blood-2016-03-643544
- Cazzola doi: 10.1182/blood-2016-03-657379
- Greenberg doi: 10.1182/blood-2016-07-728766
- Druhan doi: 10.1182/blood-2016-07-730606
- Abbonante doi: 10.1182/blood-2017-04-777417
- Selimoglu-Buet doi: 10.1182/blood-2017-04-779579
- Lazarevic doi: 10.1182/blood-2017-07-793620
- Raikar doi: 10.1182/blood-2017-09-807602
- Kalpadakis doi: 10.1182/blood-2018-02-833608
References
-
- Arber DA, Orazi A, Hasserjian R, et al. . The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391-2405. - PubMed
-
- Wartiovaara-Kautto U, Hirvonen EAM, Pitkänen E, et al. . Germline alterations in a consecutive series of acute myeloid leukemia [published online ahead of print 10 April 2018]. Leukemia. doi:10.1038/s41375-018-0049-5. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
